Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers
β Scribed by L. Cominacini; M. M. R. Young; A. Capriati; U. Garbin; A. Fratta Pasini; M. Campagnola; A. Davoli; A. Rigoni; G. B. Contessi; V. Lo Cascio
- Book ID
- 105821820
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 95 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Autoantibodies to oxidized low density lipoprotein have been shown to be an independent predictor of the progression of carotid atherosclerosis. This study examines the relationship between low density lipoprotein fatty acid composition and autoantibodies to both malondialdehyde-modified and copper-
Objective. To examine the resistance to oxidation of low-density lipoproteins (LDL) from patients with systemic sclerosis (SSc) and primary Raynaud's phenomenon (RP) compared with healthy controls. Methods. Plasma LDL were isolated from patients with diffuse cutaneous and limited cutaneous SSc (dcS
Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to